Iovance Biotherapeutics
IOVA
IOVA
80 hedge funds and large institutions have $198M invested in Iovance Biotherapeutics in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 36 increasing their positions, 18 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
39% less capital invested
Capital invested by funds: $325M → $198M (-$128M)
Holders
80
Holding in Top 10
2
Calls
$495K
Puts
$538K
Top Buyers
| 1 | +$3.86M | |
| 2 | +$2.47M | |
| 3 | +$2.08M | |
| 4 |
BC
Broadfin Capital
New York
|
+$1.69M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
+$1.49M |
Top Sellers
| 1 | -$6.96M | |
| 2 | -$1.97M | |
| 3 | -$1.71M | |
| 4 |
PP
PDT Partners
New York
|
-$631K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$585K |